Berumen, Jaime http://orcid.org/0000-0001-6707-3317
Orozco, Lorena
Gallardo-Rincón, Héctor
Rivas, Fernando
Barrera, Elizabeth
Benuto, Rosa E.
García-Ortiz, Humberto
Marin-Medina, Melissa
Juárez-Torres, Eligia
Alvarado-Silva, Anabel
Ramos-Martinez, Espiridión
MartÍnez-Juárez, Luis Alberto
Lomelín-Gascón, Julieta
Montoya, Alejandra
Ortega-Montiel, Janinne
Alvarez-Hernández, Diego-Abelardo
Larriva-Shad, Jorge
Tapia-Conyer, Roberto
Funding for this research was provided by:
Instituto Carlos Slim de la Salud
Laboratórios Huella Genica
Article History
Received: 9 March 2023
Accepted: 24 May 2023
First Online: 8 June 2023
Declarations
:
: This study was approved by the Ethics and Research Committees of the National Institute of Genomic Medicine and the Federal Commission for the Protection against Health Risks (COFEPRIS; approval number CAS/OR/CMN/113300410D0027-0577/2012). The study was carried out in accordance with the ethical principles outlined in the 1964 Declaration of Helsinki. Written informed consent was obtained from all participants prior to their inclusion in the study. This study was not registered in a clinical trial registry.
: Not applicable.
: HGR, LAMJ, JLG, AM, JOM, and DAAH are employed by the Fundación Carlos Slim. All other authors have nothing to disclose.